The prefrontal cortex plays a key role in the control of higher brain functions and is involved in the pathophysiology and treatment of schizophrenia. Here we report that ∼60% of the neurons in rat and mouse prefrontal cortex express 5-HT 1A and/or 5-HT 2A receptor mRNAs, which are highly co-localized ( 
Introduction
The prefrontal cortex is involved in higher brain functions such as working memory or behavioral inhibition (Fuster, 2001; Miller and Cohen, 2001) . Its medial aspect in rodents (medial prefrontal cortex, mPFC) controls, via the excitatory axons of pyramidal neurons, the activity of many subcortical areas, including the midbrain aminergic nuclei [ventral tegmental area (VTA), raphe nuclei and locus coeruleus] which, in turn, project back to the prefrontal cortex (Groenewegen and Uylings, 2000) . Prefrontal function and metabolism is altered in patients with severe psychiatric disorders (Weinberger et al., 1994; Andreasen et al., 1997; Drevets, 2001 ) and cognitive deficits in schizophrenia patients are mediated by derangements in brain circuits involving the prefrontal cortex (Bertolino et al., 2000; Elvevag and Goldberg, 2000) . Consistent with the pivotal role of dopamine in prefrontal function (Glowinski et al., 1984; Williams and Goldman-Rakic, 1995; Goldman-Rakic, 1996; Robbins, 2000; O'Donnell, 2003) , neuroimaging studies have revealed abnormalities in the ascending dopamine pathways in schizophrenia (Laruelle et al., 1996; Abi-Dargham et al., 2002) . Also, a reduced density of dopamine axons in deep cortical layers has been reported in post-mortem samples from schizophrenic patients (Akil et al., 2000) .
Less is known, however, on the role of serotonin (5-hydroxytryptamine, 5-HT) in prefrontal function, despite the fact that this area is innervated by 5-HT axons and is highly enriched in various receptors, notably the 5-HT 1A and 5-HT 2A subtypes (Azmitia and Segal, 1978; Blue et al., 1988; Pompeiano et al., 1992 Pompeiano et al., , 1994 Hall et al., 2000; Talvik-Lotfi et al., 2000; Martinez et al., 2001; Arango et al., 2002) . Clues about a role for serotonergic transmissionand in particular, of 5-HT 1A and 5-HT 2A receptors -in the normal and pathological function of the prefrontal cortex are numerous, such as (i) some hallucinogens (e.g. LSD, DOI) are 5-HT 2A agonists and atypical antipsychotics are 5-HT 2A antagonists (Kroeze and Roth, 1998; Meltzer, 1999) , (ii) prefrontal 5-HT 2A receptors are involved in working memory (Williams et al., 2002) , (iii) 5-HT 1A receptors are involved in anxiety (Heisler et al., 1998; Parks et al., 1998) and learning (Harder and Ridley, 2000) and (iv) some 5-HT receptors are abnormal in the frontal lobes of psychiatric patients (Arango et al., 1997; Sargent et al., 2000; Gurevich et al., 2002) . Furthermore, 5-HT 1A and 5-HT 2A receptors mediate the changes in prefrontal dopamine release induced by atypical antipsychotics (Ichikawa et al., 2001) .
Both receptors are expressed by pyramidal neurons (Kia et al., 1996; Willins et al., 1997; Goldman-Rakic, 1998, 2000; De Felipe et al., 2001; Martín-Ruiz et al., 2001) . 5-HT 2A receptors are also present in GABA interneurons (Willins et al., 1997; Jakab and Goldman-Rakic, 2000) and putative catecholaminergic axons in mPFC (Miner et al., 2003) . 5-HT 1A and 5-HT 2A receptors mediate, respectively, the hyperpolarizing and depolarizing actions of 5-HT on prefrontal neurons in vitro, although both actions have been reported for 5-HT 2A receptors (Araneda and Andrade, 1991; Tanaka and North, 1993; Marek, 1997, 1999; Zhou and Hablitz, 1999) . Given the potential relevance of both receptors in the function of the prefrontal cortex, we studied their possible co-expression in prefrontal neurons and the effects of their in vivo activation at cellular and circuit level in the brain of rats and mice. Additional interest to study the localization and function of such receptors in prefrontal cortex stems from the observations that (i) mPFC pyramidal neurons project to the ventral tegmental area (Thierry et al., 1983) , including those sensitive to the 5-HT 2A/2C agonist 1-[2,5-dimethoxy-4-iodophenyl-2-aminopropane] (DOI; Puig et al., 2003) and (ii) the firing and terminal release of dopamine cells in the VTA is controlled by 5-HT 1A and 5-HT 2A receptors (Lejeune and Millan, 1998; Ichikawa et al., 2001) . Overall, a better knowledge of the localization and function of both receptors in prefrontal cortex may improve our understanding of the pathophysiology and treatment of schizophrenia.
Animals
Male albino Wistar rats weighing 250-320 g and C57BL/6 mice, 10-12 weeks old at the time of experiments, were used (Iffa Credo, Lyon, France). 5-HT 1A receptor knockout KO(-/-) mice (referred onwards as KO) had the same genetic background than their wild-type (WT) counterparts (C57BL/6) and were engendered as previously generated at Princenton University (Parks et al., 1998) . From this initial source a stable colony was grown in the animal facility of the University of Barcelona School of Medicine. Animals were kept in a controlled environment (12 h light-dark cycle and 22 ± 2°C room temperature) with food and water provided ad libitum. Animal care followed the European Union regulations (O.J. of E.C. L358/1 18/12/1986) and was approved by the Institutional Animal Care and Use Committee.
Stereotaxic coordinates were taken from bregma and duramater according to the atlas of Paxinos and Watson (1998) for rat and Franklin and Paxinos (1997) for mouse. Additionally, we used the brain maps (Swanson, 1998) for nomenclature of the cortical areas. The location of probes and stimulation electrodes was verified histologically.
Tissue Preparation
Frozen whole brains from rats and from 5-HT 1A receptor KO and WT mice were used. Tissue sections, 14 µm thick, were cut using a microtome-cryostat (HM500-OM Microm, Walldorf, Germany), thawmounted onto 3-aminopropyltriethoxysilane (APTS; Sigma, St Louis; MO)-coated slides, and kept at -20°C until use.
Synthesis of Hybridization Probes
Different oligonucleotides were used to detect 5-HT 1A and 5-HT 2A receptor mRNA in rat brain (Pompeiano et al., 1992 (Pompeiano et al., , 1994 . Four oligonucleotides complementary to different regions of the mRNA coding for the rat 5-HT 1A receptor were used simultaneously, corresponding to the 5′ untranslated region (bases 82-122), amino terminus (bases 123-171), third cytoplasmic loop (bases 885-933) and carboxy terminus (bases 1341-1389) (Albert et al., 1990) . Three oligonucleotides complementary to the mRNA coding for 5-HT 2A receptor, corresponding to the amino terminus (bases 669-716), third cytoplasmic loop (bases 1882-1520) and carboxy terminus (bases 1913-1960) (Pritchett et al., 1988) were used. Probes were synthesized on a 380 Applied Biosystem DNA synthesizer (Foster City Biosystem, Foster City, CA) and purified on a 20% polyacrylamide/8 M urea preparative sequencing gel.
Each 5-HT 2A receptor oligodeoxyribonucleotide (2 pmol) was individually labeled at its 3′ end with [ 33 P]α-dATP (>3000 Ci/mmol; Amersham Pharmacia Biotech, Little Chalfont, UK) using terminal deoxynucleotidyltransferase (TdT; Roche Diagnostics GmbH, Mannheim, Germany). Labeled probes were purified through QIAquick Nucleotide Removal columns (QIAGEN GmbH, Hilden, Germany). The four 5-HT 1A receptor mRNA probes (100 pmol of each) (Pompeiano et al., 1992) were labeled by 3′-end tailing with TdT and digoxigenin-11-dUTP (Roche Diagnostics GmbH). Digoxigenin (Dig)-labeled oligonucleotides were purified as mentioned above.
In Situ Hybridization Histochemistry Procedure
The protocol for double-label in situ hybridization histochemistry was based on previously described procedures (Tomiyama et al., 1997; Landry et al., 2000) and has been reported elsewhere . For hybridization, the radioactively labeled and Dig-labeled probes were pooled at final individual concentrations of ∼1.5 nM. Dig-labeled 5-HT 1A hybridized oligonucleotides were visualized with alkaline-phosphate-conjugated anti-digoxigenin-F(ab) fragment antibody color reaction. Sections were then dipped into Ilford K5 nuclear track emulsion (Ilford, Mobberly, UK), exposed in the dark at 4°C for 6 weeks and then developed.
Tissue sections were examined in a Wild 420 macroscope (Leica, Heerbrugg, Germany) and in a Nikon Eclipse E1000 microscope (Nikon, Tokyo, Japan) equipped with bright-and dark-field condensers for transmitted light. Micrography was performed using a digital camera (DXM1200 3.0, Nikon) and analysis software (soft Imaging system GmbH, Münster, Germany). 5-HT 1A mRNA positive neurons were identified as cellular profiles showing dark staining (alkaline phosphatase reaction product) clearly distinguishable from background. 5-HT 2A mRNA positive neurons were identified as aggregations of grouped silver grains that were at least three times greater than background. Figures were prepared for publication using Adobe Photoshop software (Adobe Software, Mountain View, CA). the firing rate of DR 5-HT neurons in WT and KO mice. These were performed as previously described (Sawyer et al., 1985; Celada et al., 1996) once adapted to mouse brain. Mice were anesthetized with chloral hydrate (400 mg/kg i.p.) and additional doses (80 mg/kg) were administered i.v. through the femoral vein. A 2 × 2 mm recording hole was drilled over the lambda suture and the sagittal sinus was ligated, cut and reflected. Single unit extracellular recordings were carried out along the midline at approximately -4.6 mm from bregma. 5-HT neurons were usually encountered at 2-3.5 mm below the brain surface and identified according to previously described electrophysiological criteria (Wang and Aghajanian, 1977) . Serotonergic neurons exhibited a 2-5 ms bi-or triphasic extracellular waveform with regular firing rate and frequencies of 0.3-3.4 Hz.
Microdialysis Procedures
Microdialysis experiments in rats were conducted as described in Martín-Ruiz et al. (2001) . Briefly, rats were anesthetized with sodium pentobarbital (60 mg/kg, i.p.) and stereotaxically implanted in mPFC with concentric dialysis probes equipped with a Cuprophan membrane (4 mm long) at the following coordinates (in mm): AP +3.2, L -0.8, DV -6.0. Microdialysis experiments were performed in freely moving rats the day after surgery. After a 100 min stabilization period, four fractions were collected to obtain basal values before local (reverse dialysis) or systemic administration of drugs and then successive 20 min (30 µl) dialysate samples were collected. In most experiments, the partial 5-HT 2A/2C receptor agonist DOI was perfused alone for 2 h (six fractions), followed by its application in combination with other drugs for another 2 h period. For mice, the manufacture of the probes was adapted from that previously described for rats. Surgical and microdialysis procedures were identical to those described for rats except for the dose of anesthesia (sodium pentobarbital, 40 mg/kg, i.p.), the length of dialysis membrane (2 mm) and the brain coordinates (in mm) of the mPFC: AP +2.2, L -0.2, DV -3.4.
The concentration of 5-HT in dialysate samples was determined by HPLC with amperometric detection, as described (Adell and Artigas, 1998) . Retention time was between 3.5 and 4 min and the limit of detection was typically 1 fmol/sample. The HPLC profile from mice and rats were similar and the 5-HT peak was free from interferences.
5-HT 1A and 5-HT 2A Receptor Inactivation in Rats
To assess the involvement of 5-HT 2A and 5-HT 1A receptors in the actions of DOI and the various 5-HT 1A agonists used, we used two different experimental strategies. On the one hand, the function of 5-HT 1A receptors in mPFC was cancelled by the local application of pertussis toxin, which ADP-ribosylates G i/o proteins associated to preand postsynaptic 5-HT 1A receptors (Andrade et al., 1986; . Pentobarbital anesthetized rats were positioned in the stereotaxic frame and pertussis toxin (1 µg in 2 µl of aCSF) was infused through a 25 gauge stainless steel cannula (Small Parts Inc., Miami, FL) at two different DV coordinates (-3.0 and -5.0 mm) using the same AP and L coordinates than for probe implants. (AP +3.2, L -0.8). At each application point, the solution containing pertussis toxin was delivered over the course of 2 min using a 10 µl Hamilton syringe attached to a microinfusion pump (Bioanalytical Systems Inc., West Lafayette, IN) and the cannula was left in position for ∼10 min to prevent the solution from surging back. Control rats were subjected to the same procedure but no pertussis toxin was applied. Microdialysis experiments were performed 2-3 days after pertussis toxin. In the rats examined 2 days later, a dialysis probe was implanted 1 h after the application of pertussis toxin, to avoid a second surgical procedure. However, in rats examined 3 days later, probes were implanted the day before microdialysis experiments (i.e. 2 days after pertussis toxin administration) to avoid an excessive gliosis resulting from probe implant 3 days later.
A second strategy to examine the involvement of 5-HT 2A and 5-HT 1A receptors in the actions of DOI and BAY × 3702, respectively, was the use of EEDQ. Since this agent alkylates several G-coupled aminergic receptors, we used the following approach to selectively protect 5-HT 2A or 5-HT 1A receptors from the effect of EEDQ. Rats were implanted with microdialysis probes in the mPFC, as above. At 3-4 h after implants, the probes were perfused with the 5-HT 2A/2C antagonist ritanserin (300 µM) for 3 h at 1.5 µl/min. One hour after beginning of the perfusion, EEDQ was dissolved in ethanol:water (1:1) and administered to the rats (6 mg/kg, i.p.). It was hypothesized that the occupation of 5-HT 2A receptors by ritanserin in the area sampled by the microdialysis probe would prevent the inactivation of the receptor by EEDQ. This strategy has been previously used in vitro (Gozlan et al., 1994) . Similarly, to protect 5-HT 1A receptors, the same procedure was applied, but the selective 5-HT 1A antagonist WAY-100635 was perfused before EEDQ administration instead of ritanserin. Microdialysis experiments were performed on the following day.
Data and Statistical Analysis
The statistical analysis of histological data was performed using oneway analysis of variance (ANOVA) followed by post-hoc testing to determine regional differences in the expression of 5-HT 1A and 5-HT 2A receptor. Only cellular profiles showing great abundance of both transcripts were considered to co-express both receptors. Cells with a dense labeling of 5-HT 1A receptor mRNA and occasional silver grains or vice versa (e.g., as shown in Fig. 1I) were not considered to coexpress both receptors.
The responses in prefrontal pyramidal neurons evoked by DR and MnR stimulation were characterized by measuring the magnitude and duration of inhibitory and excitatory responses from peristimulustime histograms (PSTH; 4 ms width). Orthodromic excitations elicited spikes with short and variable latencies with a success rate >10% . These have been previously characterized in Puig et al. (2003) . Inhibitions were defined by either a total cessation of spikes or a 75% decrease in the number of spikes with respect to the prestimulus value for at least four successive bins (Hajós et al., 1998) . These were pharmacologically characterized by reversal with the selective 5-HT 1A antagonist WAY-100635. The offset of the inhibition was defined as the first of four bins equal to or above the prestimulus value. Changes in firing rate of 5-HT neurons were assessed using paired Student's t-test or repeated-measures ANOVA. These were quantified by averaging the values after i.v. drug injection (omitting the first minute). ED 50 values were calculated with the GraphPad Prism program (San Diego, CA).
Microdialysis results are expressed as fmol/fraction (uncorrected for recovery) and shown in figures as percentages of basal values (individual means of four pre-drug fractions). Statistical analysis was carried out using one-or two-way ANOVA for repeated measures of the 5-HT values followed by Duncan test. Typically, experiments consisted in the perfusion of DOI or S-AMPA by reverse dialysis in mPFC for 2 h followed by another 2 h period in which 5-HT 1A agonists were co-perfused. Drug effects were assessed using 5-HT values in four pre-drug fractions plus the six post-drug (2 h) fractions. When appropriate, average 5-HT values were calculated and compared using student's t-test or ANOVA. Data are expressed as the mean ± SEM. Statistical significance has been set at the 95% confidence level (two tailed).
Results

Co-expression of 5-HT 1A and 5-HT 2A Receptors
Rat Prefrontal Cortex
We used double in situ hybridization to examine the presence of 5-HT 1A and 5-HT 2A receptor mRNAs in rat prefrontal cortex. Figure 1 (A,B) shows the presence of a large number of cells containing both transcripts in superficial, middle and deep layers. At this magnification, a marked overlap in the distribution of both receptors was observed in various cortical areas, such as secondary motor area (MOs), dorsal anterior cingulate area (ACAd), prelimbic area (PL) and infralimbic area (ILA), as well as in the piriform cortex (PIR) or taenia tecta (TT). This was also evident at higher magnification in the cingulate, prelimbic and infralimbic areas of the medial prefrontal cortex (mPFC), which contain numerous cells expressing 5-HT 1A and/ or 5-HT 2A receptor mRNAs (Fig. 1D ,E,G). However, internal layers (VI) contain fewer cells expressing 5-HT 2A than 5-HT 1A receptors (compare left sides of panels Fig. 1D and E). As evidenced from Nissl-stained sections (Fig. 1C,F ) the proportion of cells expressing 5-HT 1A and/or 5-HT 2A receptors was high in all prefrontal areas. Figure 1G and H show the presence of abundant cells containing both receptor transcripts in the infralimbic (Fig. 1G ) and piriform cortices (Fig. 1H) . Figure 1I and J show at a higher magnification, the cells in infralimbic cortex (Fig. 1I ) and taenia tecta (Fig. 1J ) expressing both receptor transcripts as well as occasional cells in which 5-HT 1A and 5-HT 2A receptors were not co-localized.
We used total cell counts obtained from adjacent Nisslstained sections to calculate the proportion of cells in prefrontal cortex expressing 5-HT 1A and/or 5-HT 2A receptor mRNAs. These values ranged from 53 to 65% (Table 2 ). The coexpression of both receptors was very high (80-90%) in all cortical areas examined, except in layer VI (38%; Table 2 ).
Mouse Prefrontal Cortex
The mouse mPFC showed the presence of abundant cells in which both 5-HT 1A and 5-HT 2A receptor transcripts were present, with a marked overlap in their distributions ( Fig.  2A ,B). The proportion of cells expressing one or the other receptor (or both) varied between 52% in layer VI to 71% in cingulate area (Table 3 ). The proportion of cells containing both receptor mRNAs was 76% in the cingulate area, 72% in the infralimbic area, 48% in layer VI and 82% in the piriform area (Table 3 ). The percentage of co-expression in deep layers was significantly lower than that in the other areas examined. We performed autoradiographic studies in wild-type (WT) and 5-HT 1A receptor knockout [KO(-/-)] mice to examine whether the genetic deletion of 5-HT 1A receptors had altered 5-HT 2A receptors in prefrontal cortex. The density of 5-HT 2A receptor binding sites in the cingulate area (see Materials and Methods) was 476 ± 19 fmol/mg protein in WT mice and 510 ± 13 fmol/mg protein in 5-HT 1A receptor KO(-/-) mice (n.s.).
Opposite In Vivo Action of 5-HT 1A and 5-HT 2A Receptors on Pyramidal Cells
Pyramidal neurons in the mPFC, systematically identified by antidromic stimulation from the DR and MnR were recorded extracellularly. The electrical stimulation of the raphe nuclei could excite and inhibit pyramidal neurons. Here we describe only the characteristics of the responses which were pharmacologically characterized by the use of selective antagonists. 5-HT 2A -mediated excitations (n = 10) were reversed by M100907 (0.2-0.6 mg/kg i.v.; Fig. 3A ,B). Excitations had a mean latency of 71 ± 8 ms and a mean duration of 101 ± 8 ms. The success rate dropped after M100907 administration from 47 ± 8% to 11 ± 3% (P < 0.001). In all cases, orthodromic and antidromic spikes were simultaneously recorded, showing the existence of a strong reciprocal raphe-mPFC interaction. Two additional neurons (out of 12) were excited by DR stimulation but the response was not reversed by M100907 (up to 0.6 mg/kg).
Likewise, the electrical stimulation of the DR and MnR inhibited mPFC pyramidal neurons. The 5-HT 1A antagonist WAY- 100635 (10-60 µg/kg i.v) reversed these inhibitions in 8/10 cases examined (Fig. 3C,D) . WAY-100635 did not reverse a short latency/duration inhibition (see Discussion for an explanation of the putative mechanisms involved). We therefore omitted this earlier component in the calculations. 5-HT 1A -mediated inhibitions had a latency of 69 ± 32 ms and a duration of 181 ± 84 ms. Within this time period, raphe stimulation inhibited mPFC pyramidal neurons by 87 ± 15%. The administration of WAY-100635 reversed this inhibition to -30 ± 80%, i.e. 5-HT 1A receptor blockade unveiled a latent excitation, which was noticeable in four out of the eight units whose inhibition was blocked by WAY-100635, as in the example shown in Figure 4F . This suggests that some of the recorded units were concurrently excited and inhibited by raphe stimulation, although the overall effect was inhibitory.
The high co-expression of 5-HT 1A and 5-HT 2A receptors in prefrontal neurons seemed paradoxical in view of their opposite cellular responses to 5-HT. We hypothesized that 5-HT might excite or inhibit a given pyramidal neuron depending on (i) the amount of 5-HT released, or (ii) the existence of specific connections between the stimulated 5-HT neurons and pyramidal compartments enriched in one or other receptor (see Discussion). We tested the first possibility by recording pyramidal neurons after single or twin pulse stimulation of the DR/ MnR. The results are given in a separate report (M.V. Puig et al., in preparation) . In general, twin pulse stimulation, which increases 5-HT release (Gartside et al., 2000) also enhanced the magnitude of the inhibitory effect.
To examine the second possibility, we conducted a series of experiments in which we recorded the same pyramidal neuron while stimulating the DR and the MnR at different sites (two in the DR, one in MnR; see Experimental Procedures). Once a pyramidal neuron was identified, stimulation began in one of these sites to evoke a response, which was recorded for 2-4 min. Then, the current was switched to an electrode implanted in another coordinate within the raphe nuclei while recording the same neuron. Due to the experimental paradigm used, we could not pharmacologically assess these responses, yet their characteristics did not differ from those blocked by 5-HT 2A and 5-HT 1A antagonists. A total of 56 experiments were done in which pyramidal responses differed -qualitatively or quantitatively -depending on the site of placement of the stimulating electrode within the raphe (three electrodes were stably implanted; see Experimental Procedures). Figure 4 (A-E) shows examples of several of these experiments. In 14 cases, the response changed from an excitation to an inhibition (or Table 2 Co-expression of 5-HT 1A and 5-HT 2A receptor mRNA in rat prefrontal cortex Cortical areas designated according to Paxinos and Watson (1998) and Swanson (1998) . MOs, secondary motor area; ACAd, dorsal anterior cingulate area; ILA, infralimbic area (dorsal part); PIR, piriform cortex; TT, taenia tecta. Layer VI denotes deep areas of the sensorimotor cortex at prefrontal level, as shown in Fig. 1C (Swanson, 1998) . Data are means ± SEM of five rats (each individual measure is the mean of four consecutive sections) and represent the percentage of the counted cells expressing both, or each mRNA receptor subtype individually. Values in italics are the percentage of the cells in each prefrontal area expressing each receptor (or both), calculated as the ratio between the number of cells expressing either (or both) receptors(s) and the total number of cells in the same field counted in adjacent sections (Nissl staining). The latter value was 1026 ± 56 cells/field (field was 1 mm 2 ). *P < 0.05 versus cingulate and infralimbic areas; **P < 0.05 versus all other areas (post-hoc test after ANOVA). 5-HT1A mRNA 11.5 ± 1.0% 14.6 ± 1.9% 16.7 ± 1.3% 59.4 ± 1.8%** 7.4 ± 1.0%* 9.5 ± 0.8%* 7 9 9 3 3 5 6
5-HT2A mRNA 4.8 ± 0.6% 4.0 ± 0.5% 3.8 ± 0.2% 3.4 ± 1.1% 2.7 ± 0.6% 2.8 ± 0.7% vice versa). In three of them, the excitation was preceded by an inhibition lasting for ∼100 ms (Fig. 4A′) . In another 14 experiments, switching the stimulation site inhibited a previously unresponsive neuron (or vice versa; Fig. 4B′ ). Also, a change from no response to excitation (or vice versa) was observed in six cases (Fig. 4C′) . In 22 cases, the nature of the response did not change (15 inhibitions; seven excitations) but the effect size differed when switching the stimulation site (9/15 for inhibitions, 4/7 for excitations). As shown in the examples in Figure 4 , excitations and inhibitions could be indistinctly evoked by DR or MnR stimulation. Lastly, to verify the reversibility of these effects, in some experiments we further switched the stimulation site back to the original one and the response was recorded for another 2 min period (n = 7). tion of excitatory (AMPA, 5-HT 2A ) and inhibitory (5-HT 1A ) receptors in mPFC, increases and decreases, respectively (i) pyramidal cell firing, (ii) 5-HT cell firing in the DR, and (iii) 5-HT release in mPFC Martín-Ruiz et al., 2001; Puig et al., 2003) . Here we used the drug-evoked in vivo 5-HT release in mPFC as an overall index of the pyramidal influence on ascending midbrain 5-HT neurons.
Microdialysis Studies in Rats
A total of 123 rats were used in these studies. Baseline 5-HT values were 20.3 ± 1.0 fmol/fraction. As previously observed, local DOI application (100 µM) in rat mPFC doubled 5-HT release (n = 10, P < 0.0001; Fig. 5A ). This effect depends on 5-HT 2A receptor activation (Martín-Ruiz et al., 2001) and was reversed by co-perfusion of the following 5-HT 1A receptor agonists: 8-OH-DPAT (100 µM, n = 8), alnespirone (300 µM, n = 6), BAY × 3702 (30 µM, n = 7), buspirone (300 µM, n = 6) and ipsapirone (300 µM, n = 5; data not shown) (Fig. 5A) . Two-way ANOVA revealed a significant effect of the group (P < 0.0025), time (P < 0.0001) and time × group interaction (P < 0.0001). The reducing effect of BAY × 3702 was antagonized by the co-perfusion of WAY-100635 (300 µM, n = 9, P < 0.007) (Fig.  5B) . A lower concentration of WAY-100635 (100 µM) could not reverse the effect of BAY × 3702 (n = 6, not shown). We further examined the involvement of postsynaptic 5-HT receptors in these effects using two strategies. First, one day before microdialysis experiments, we inactivated 5-HT 1A receptors in rat mPFC using the chelating agent EEDQ (6 mg/kg i.p.) while protecting 5-HT 2A/2C receptors with ritanserin (see Experimental Procedures). Under these conditions, the 5-HTenhancing effect of DOI did not differ from that in naïve rats (n = 7; Fig. 5C ) but the suppressing effect of BAY × 3702 was totally abolished (P < 0.0001; Fig. 5C ). In another group of rats we protected 5-HT 1A receptors from EEDQ by local WAY-100635 application (300 µM) using the same temporal schedule. In these rats, DOI elicited a very modest 5-HT increment (25 ± 13%) which clearly differed from controls (P < 0.0001) whereas BAY × 3702 30 µM was fully effective to reduce 5-HT release (∼50% of the initial baseline; Fig. 5C ).
We also inactivated the function of 5-HT 1A receptors with pertussis toxin (PTx) (see Experimental Procedures). Figure  5D shows the effect of the co-perfusion of DOI and BAY × 3702 Effects of the local pretreatment with pertussis toxin (PTx) in mPFC (1 µg, 2 or 3 days before) on the inhibitory action of BAY × 3702 30 µM compared to control rats and shamoperated rats (n = 4). Filled triangles (n = 5) and squares (n = 7) correspond to rats receiving the toxin 2 and 3 days before, respectively. Inset: effect of BAY × 3702 expressed as pre-drug value in each group; *P < 0.0001. (E) Effects of the systemic administration of BAY × 3702 (0.1 mg/kg s.c.) on mPFC 5-HT release in control rats and in rats pretreated with PTx 3 days before (n = 6 and 7, respectively) *P < 0.0001 versus controls. (F) The local application of S-AMPA (300 µM) in mPFC increased the local 5-HT release (n = 5). BAY × 3702 (30 µM) suppressed the AMPA-induced 5-HT release (n = 5). In a small group of rats (n = 3), 8-OH-DPAT (100 µM) also attenuated the AMPA-induced 5-HT release. *P < 0.0001 versus AMPA alone.
(30 µM) in control rats (n = 7), sham-operated rats (n = 4) and in rats pretreated with PTx (1 µg) 2-3 days before (n = 5 and 7, respectively). The reducing effect of BAY × 3702, expressed as pre-drug values (1 h periods, fractions 14-16 versus 8-10) was 43 ± 4% in control rats, 46 ± 2% in sham-operated rats, 71 ± 5% and 84 ± 8% in PTx-treated rats respectively (inset in Fig. 5D ) (P = 0.00115). PTx (3 days before) also attenuated the suppressing effect of BAY × 3702 (0.1 mg/kg, s.c.) on 5-HT release in mPFC (18% of baseline in controls, 55% in PTxtreated rats; n = 6 and 7, respectively; P < 0.0001; Fig. 5E ), as this effect involves pre-and postsynaptic 5-HT 1A receptors (Casanovas et al., 1999) .
S-AMPA application (300 µM, n = 5) also elevated mPFC 5-HT release (P < 0.0001). The co-perfusion of 8-OH-DPAT (100 µM, n = 3) and BAY × 3702 (30 µM, n = 5) also attenuated the 5-HTenhancing effect of S-AMPA (P < 0.0001; Fig. 5F ).
In Vivo Studies in WT and 5-HT 1A KO Mice
We used 5-HT 1A KO mice (Parks et al., 1998) to further verify the specificity of the responses elicited by 5-HT 1A agonists. Autoradiographic studies using [ 3 H]WAY-100635 showed the lack of hippocampal 5-HT 1A receptors in 5-HT 1A KO mice (Fig.  6A) . The absence of functional 5-HT 1A receptors was determined using extracellular recordings of DR 5-HT neurons. Basal firing rate of DR 5-HT neurons in WT and KO mice was 1.6 ± 0.2 and 1.7 ± 0.2 spikes/s (n = 26 and 20, respectively; n.s.). 8-OH-DPAT (2-32 µg/kg i.v., cumulative doses) dose-dependently inhibited the firing rate of 5-HT neurons in WT mice (n = 10, P < 0.0001; Fig. 6B,D) with an ED 50 value of 6.8 µg/kg but failed to significantly reduce cell firing in KO mice (n = 6; Fig. 6C,D) . Similarly, the 5-HT reuptake inhibitor fluoxetine (2-32 mg/kg i.v., cumulative doses) suppressed 5-HT cell firing in WT mice (n = 4; ED 50 = 7.6 mg/kg, P < 0.0001; Fig. 6E,H) but not in KO mice (n = 4; Fig. 6F-H) . However, 5-HT neurons in KO mice were fully responsive to the α 1 -adrenoceptor antagonist prazosin (up to 4.5 mg/kg i.v., ED 50 = 2.7 mg/kg i.v., n = 5; Fig. 6C,F) .
In microdialysis experiments we used 56 WT mice and 50 KO mice. Baseline 5-HT release in the mPFC was 14.1 ± 1.0 and 13.7 ± 1.0 fmol/fraction in WT and KO mice, respectively (n.s.). The perfusion of artificial CSF did not significantly alter the prefrontal 5-HT output in WT and KO mice (n = 6 and 4, respectively) although 5-HT release was less stable in KO mice (i.e. saw-tooth oscillations; Fig. 7A ). The local application of DOI (30, 100, 300 and 500 µM) in the mPFC increased dosedependently the 5-HT output to a similar extent in the mPFC of WT and KO mice (n = 5; Fig. 7B ). The concentration of 100 µM was chosen for subsequent experiments. The perfusion of DOI 100 µM stably increased 5-HT release (Fig. 7C) . In a separate report, we describe the mechanisms involved in the effect of DOI on 5-HT release in WT mice (Bortolozzi et al., 2003) . We used the data from some groups included in that study for statistical analysis of WT-KO differences. The perfusion of M100907 (300 µM) reversed the effect of DOI on 5-HT release in WT and KO mice (n = 5 and 7, respectively; P < 0.0001 time effect, non-significant differences between groups; Fig. 7C ).
The perfusion of BAY × 3702 (30 µM) markedly reduced the 5-HT release in the mPFC of WT but not of KO mice (n = 5 and 10 respectively, P < 0.001; Fig. 7D ). BAY × 3702 also reversed the 5-HT elevation induced by the local application of DOI in mPFC of WT but not KO mice (n = 8 each, P < 0.0003; Fig. 7E ). Likewise, 8-OH-DPAT (100 µM) significantly reduced 5-HT release in WT but not KO mice (n = 6 and 4 respectively; P < 0.001; Fig. 7D ) and reversed the DOI-induced facilitation of 5-HT release in WT but not KO mice (n = 5 and 4, respectively; data not shown).
As observed in rats (Fig. 5 ) the perfusion of S-AMPA in the mPFC of mice increased 5-HT release. This effect was fully counteracted by the co-perfusion of BAY × 3702 (30 µM) in WT (n = 5) but not KO mice (n = 7, P < 0.0001; Fig. 7F ).
Discussion
The main findings of the present study are that (i) nearly 60% of the prefrontal cells contain the mRNA encoding 5-HT 1A and/ or 5-HT 2A receptors, with a very high degree (80%) of co-localization, (ii) endogenous 5-HT modulates the activity of pyramidal neurons in vivo through these receptors, (iii) the response elicited by 5-HT (excitation or inhibition) possibly depends on the existence of precise projections from the raphe cells to areas of the pyramidal neurons rich in 5-HT 2A or 5-HT 1A receptors and (iv) drug-induced activation of 5-HT 1A and 5-HT 2A receptors in mPFC modulates the pyramidal output to the raphe nuclei -and possibly other subcortical areas -in an opposite manner.
Co-expression of 5-HT 1A and 5-HT 2A Receptors in Rodent Prefrontal Cortex
The high number of neurons expressing the 5-HT 1A and 5-HT 2A receptor mRNAs accords with the very high density of the respective proteins in rodent prefrontal cortex, particularly in its medial aspect. Previous studies revealed an overlap in the distribution of 5-HT 1A and 5-HT 2A receptors in prefrontal cortex Pompeiano et al., 1992 Pompeiano et al., , 1994 and suggested some coexistence in pyramidal neurons (Araneda and Andrade, 1991; Ashby et al., 1994; Martín-Ruiz et al., 2001 ). The present data indicate that the co-expression of both receptors is the general rule in the various prefrontal areas examined, except in layer VI, where 5-HT 1A receptor mRNA predominates. Notably, the prelimbic and infralimbic areas of the mPFC, which project to the midbrain serotonergic and dopaminergic nuclei (Hajós et al., 1998; Peyron et al., 1998; Carr and Sesack, 2000) We are unaware of similar data for other neurotransmitter receptors (e.g. dopaminergic) in prefrontal cortex. However, the large proportion of cells expressing 5-HT 1A or 5-HT 2A receptors suggest an important serotonergic control of prefrontal function in the rodent brain. Indeed, in vitro recordings have revealed that prefrontal pyramidal neurons respond to 5-HT applications with inhibitory and excitatory responses (see Introduction). Moreover, in vivo recordings of presumed (Hajós et al., 2003) and identified pyramidal neurons in mPFC (Puig et al., 2003; this work) indicates that these are very sensitive to the physiological activation of 5-HT neurons. 
Pyramidal Responses Elicited by Raphe Stimulation in Rats
Early microiontophoretic studies revealed predominantly inhibitory actions of 5-HT on cortical neurons (Jacobs and Azmitia, 1992) . This effect may involve direct (5-HT 1A -mediated) and indirect (GABA-mediated) actions of 5-HT (Ashby et al., 1989 (Ashby et al., , 1990 (Ashby et al., , 1994 . In vitro intracellular recordings suggested that 5-HT 1A and 5-HT 2A receptors exert opposite effects on pyramidal excitability (see Introduction). Our in vivo observations indicate that 5-HT excites (via 5-HT 2A receptors) and inhibits (via 5-HT 1A receptors) pyramidal neurons in mPFC. All neurons recorded were activated antidromically from the DR or MnR, which supports the existence of strong reciprocal interactions between 5-HT neurons and 5-HT 1A /5-HT 2A receptor-expressing pyramidal neurons in mPFC. Moreover, in a previous study we observed that pyramidal neurons sensitive to the activation of 5-HT 2A receptors were also antidromically activated from the VTA (Puig et al., 2003) . Excitations were 5-HT 2A receptor-mediated since they were reversed by M100907, as recently reported (Puig et al., 2003) . Inhibitions lasted more than excitations and involved 5-HT 1A receptors, since they were reversed by WAY-100635. The earlier component of the inhibitions (not blocked by WAY-100635, even at high doses) may be due to an increase of GABA inputs mediated by the activation of 5-HT 2A or 5-HT 3 receptors in interneurons (Ashby et al., 1989 (Ashby et al., , 1990 ; Zhou and Hablitz, 1999). Also, since the recorded neurons were antidromically activated from the DR or MnR, it may be that antidromic stimulation enhanced prefrontal glutamate release from axon collaterals and, hence, an increase in local GABA inputs onto the recorded neurons. Moreover, Susan R. Sesack and associates have reported the presence of GABAergic projection neurons from the DR to the mPFC of the rat (Janowski and Sesack, 2002) , which raises the possibility that the short latency/duration inhibitions not blocked by WAY-100635 may be due to a direct GABA synaptic input evoked by DR/MnR stimulation. Current work is examining this possibility. During the completion of the present report, Hajós et al. (2003) documented the existence of 5-HT 1A receptor-mediated inhibitions of presumed pyramidal neurons evoked by DR stimulation. However, unlike in the present report, DR-evoked inhibitions were fully blocked by WAY-100635. Differences in the location of the recorded neurons (more ventral in Hajós et al., 2003) and/or strain of rats used may account for this distinct behaviour. Occasionally, WAY-100635 unveiled a prominent 5-HT 2A -mediated excitation (as in the example in Fig. 4F ), suggesting that raphe stimulation simultaneously excited and inhibited the recorded neuron, although the inhibitory response prevailed. 5-HT 2A receptors are enriched in apical dendrites of pyramidal neurons (Willins et al., 1997; Jakab and Goldman-Rakic, 1998; Cornea-Hébert et al., 1999) and mediate the increase in pyramidal excitability induced by 5-HT application near the apical dendrites (Aghajanian and Marek, 1997 ). Yet, conflicting results have been reported for 5-HT 1A receptors, using two different antibodies. Azmitia et al. (1996) found a somatodendritic location for 5-HT 1A autoreceptors in raphe 5-HT neurons and a location in the axon hillock of cortical and hippocampal pyramidal neurons. This observation has been replicated by two other groups in primate and human brain (De Felipe et al., 2001; David E. Lewis, personal communication) . This localization is coincident with the unique cortical axo-axonic synapses such as those of GABAergic chandelier cells on the pyramidal axon hillock (Somogyi et al., 1998; De Felipe et al., 2001 ) and would assign a prominent inhibitory role to 5-HT 1A receptors in the control of pyramidal activity. On the other hand, a somatodendritic location of 5-HT 1A receptors in the DR and hippocampus has been reported using a different antibody (Kia et al., 1996; Riad et al., 2000) . The non-synaptic nature of serotonergic transmission in mammalian cortex (Beaudet and Descarries, 1978; De Felipe and Jones, 1988) appears to be discordant with a putative presence of both receptors in the same areas of pyramidal neurons, since 5-HT released from nearby axons would indistinctly activate 5-HT 1A and 5-HT 2A receptors in the proximity of release sites. Indeed, the predominance of the inhibitory response, as observed when 5-HT is applied microiontophoretically or when enhancing cortical 5-HT release (Gartside et al., 2000; Puig et al., unpublished observations; see also Fig. 4F ) suggests that 5-HT 1A receptors are located downstream of 5-HT 2A receptors in the process of spike generation. This would be consistent with a location of 5-HT 2A receptors on apical dendrites, as generally agreed, whereas 5-HT 1A receptors may be localized in cell bodies, basal dendrites and/or axon hillock. The segregation of both receptors in different compartments of the pyramidal neuron would permit that 5-HT axons terminating on (or passing near) apical dendrites would excite pyramidal neurons whereas those at lower cortical levels would result in inhibitions, as in the scheme shown in Figure 8 . Additionally, it has been proposed that the activity of prefrontal pyramidal neurons is controlled by 5-HT via GABA interneurons expressing 5-HT 2A and 5-HT 3 receptors, located at different heights in the pyramidal tree (Jakab and Goldman-Rakic, 2000) . Both proposals would be in agreement with the existence of excitatory and inhibitory inputs at different levels in cortical microcircuits regulating the output of pyramidal cells (Somogyi et al., 1998) .
A number of different observations appear to support the above view. First, cortical 5-HT axons differ in morphology, origin and regional brain targets (Kosofsky and Molliver, 1987; De Felipe and Jones, 1988; De Felipe et al., 1991) . Secondly, in rat somatosensory cortex (no such studies exist for prefrontal cortex), two dense plexuses of 5-HT axons innervate mainly layers I and Va. Between them, 5-HT axons run vertically (Blue et al., 1988) . More interestingly, vertical 5-HT axons run parallel to 5-HT 2A receptor-rich apical dendrites in rat cortex (Jansson et al., 2001) . Thirdly, although the synaptic relationships between 5-HT axons and 5-HT 1A receptors have not been studied in the rat cortex, 5-HT axons pass horizontally near 5-HT 1A -and GABA A -receptor-rich areas in the pyramidal axon hillock in monkey and human cortex (De Felipe et al., 2001) . Finally, using stably implanted stimulating electrodes and switching the current between stimulation sites within the raphe, we were able to demonstrate that the response evoked in a given pyramidal neuron depends on the site of stimulation (although, as mentioned above, inhibitory responses predominate). In contrast, stimulation with twin pulses at the same stimulation current (a procedure that enhances cortical 5-HT release; Gartside et al., 2000) , increases the duration of the inhibitions but does not turn them into excitations as it could be expected if the response in the pyramidal cell would be solely determined by the relative affinity of 5-HT for 5-HT 1A and 5-HT 2A receptors (Puig et al., in preparation) . Overall, this suggests that the axons from different individual 5-HT neurons or neuronal clusters within the raphe may have specific projections to 5-HT 1A -or 5-HT 2A -receptor-rich areas of the pyramidal neuron. Indeed, further work using refined tracing techniques is required to test this hypothesis.
Opposite Effects of 5-HT 1A and 5-HT 2A Receptor Activation on the mPFC-Raphe Circuit Pyramidal neurons in prellimibc and infralimbic mPFC project to raphe 5-HT neurons, as shown by anatomical studies (e.g. Peyron et al., 1998) and by the generalized antidromic responses observed during DR/MnR stimulation (Puig et al., 2003; this study) . We therefore used this reciprocal connectivity (mPFC-raphe circuit) to examine the interactions between prefrontal 5-HT 1A and 5-HT 2A receptors, using the in vivo 5-HT release in mPFC as an indicator of the prefrontal influence onto ascending 5-HT neurons. The application of DOI in mPFC enhanced -and that of 5-HT 1A agonists reduced -the local 5-HT release in rat and mouse brain (Casanovas et al., 1999; Celada et al., 2001; Martín-Ruiz et al., 2001; Bortolozzi et al., 2003; Puig et al., 2003) . The effect of DOI was interpreted as resulting from the activation of descending pyramidal inputs onto 5-HT neurons because (i) systemic DOI administration elicited an overall 2.4-fold increase in the firing of pyramidal cells in the anterior cingulate and prelimbic cortices (an area sampled by the probe in microdialysis studies) which was reversed in most cases by M100907 (Puig et al., 2003) and (ii) local application of DOI in mPFC increased the firing rate of some 5-HT neurons in the DR (Martín-Ruiz et al., 2001) . The effect of DOI does not appear to involve thalamocortical afferents since both the DOI-induced pyramidal cell firing and mPFC 5-HT release are insensitive to extensive thalamic lesions (Puig et al., 2003) . Moreover, the increase in mPFC 5-HT release induced by thalamic disinhibition (to increase prefrontal AMPA inputs) was abolished by the activation of µ-opioid receptors by DAMGO yet the effect of DOI was insensitive (Puig et al., 2003) . Overall, this indicates that the effect of DOI is not mediated by an increase of glutamate release from thalamic afferents. However, we cannot disregard the possibility that DOI, by virtue of its overall enhancement of pyramidal cell firing, increases the excitatory input onto putative AMPA receptor on 5-HT terminals (see Fig. 8 ).
The stimulatory effect of local DOI application on prefrontal 5-HT release and its effects on pyramidal and 5-HT cell firing appear discordant with the reported inhibitory influence of the electrical stimulation of the mPFC on DR 5-HT neurons, which appears to involve both GABA interneurons and 5-HT 1A autoreceptors Varga et al., 2001) . One possibility to reconcile both sets of data is that pyramidal neurons in more ventral regions of the mPFC -i.e. infralimbic cortex, as examined in Varga et al. (2001) -preferentially innervated GABA interneurons within the DR. Indeed, small regional differences in the stimulation site appear to have opposite influence on the activity of locus coeruleus noradrenergic neurons (Sara and Hervé-Melville, 1995; Jodo et al., 1998) . Likewise, since only a proportion of mPFC neurons express 5-HT 2A receptors, it might be also possible that chemical and electrical stimulation of the mPFC differ in their overall effect on ascending 5-HT neurons.
Despite some of the above mechanisms remain to be fully clarified, microdialysis studies have shown that DOI enhances 5-HT release in mPFC whereas 8-OH-DPAT and BAY × 3702 reduce 5-HT release in the same area of the rat brain (Casanovas et al., 1999; Celada et al., 2001; Martín-Ruiz et al., 2001; Puig et al., 2003) . We therefore conducted 5-HT 2A -5-HT 1A receptor interaction studies in rats to obtain a neurochemical correlate of the above electrophysiological data. Additionally, since these mechanisms involved in the DOI-and AMPAevoked prefrontal 5-HT release appear to be substantially similar in rat and mouse brain (Bortolozzi et al., 2003) , we repeated these studies in WT and 5-HT 1A knockout mice to fully verify the specificity of the pharmacological responses elicited by 5-HT 1A agonists. The working hypothesis was that 5-HT 1A receptor activation would attenuate or cancel the increase in mPFC 5-HT release evoked by agents that increase the activity of pyramidal neurons, such as DOI and S-AMPA (Puig et al., 2003) . (Azmitia et al., 1996; De Felipe et al., 2001 ; David E. Lewis, personal communication) or in the somatodendritic compartment (Riad et al., 2000) . We suggest that the stimulation of the DR and MnR can excite or inhibit pyramidal neurons, depending on a precise topology between certain 5-HT neurons or neuronal clusters in the DR/MnR and 5-HT 1A -or 5-HT 2A -receptor-rich compartments, in agreement with anatomical studies showing an association between 5-HT axons and such receptor-rich areas (De Felipe et al., 2001; Jansson et al., 2001) . Since the mPFC contains many neurons projecting to the DR, the pharmacological activation of 5-HT 1A and 5-HT 2A receptors modulates in an opposite way the terminal 5-HT release through changes in their activity. Although pyramidal neurons also project to midbrain GABA interneurons (particularly those in the infralimbic cortex; Varga et al., 2001 ) and can inhibit 5-HT neurons Varga et al., 2001) , the overall influence of mPFC on 5-HT release appears to be excitatory, as judged from the effects of the pharmacological stimulation of prefrontal 5-HT 1A and 5-HT 2A receptors (Casanovas et al., 1999; Celada et al., 2001; Martín-Ruiz et al., 2001; Bortolozzi et al., 2003; this study) . In addition to a distal effect (via DR) on ascending 5-HT neurons (Martín-Ruiz et al., 2001) , DOI could also increase local glutamatergic transmission by its excitatory action on pyramidal neurons (Puig et al., 2003) whose collaterals might activate AMPA receptors putatively located on 5-HT terminals. 5-HT 2A receptors in pyramidal neurons can also control the activity of dopamine neurons in the ventral tegmental area (VTA) through descending excitatory axons (Carr and Sesack, 2000) since pyramidal neurons in mPFC sensitive to the activation of 5-HT 2A receptors also project to the VTA (Puig et al., 2003) .
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